We discuss the calls to "re-open the economy" as the Senate fights over its bailout package, a coronavirus treatment that pharmaceutical company Gilead Sciences is positioning itself to sell at exorbitant cost, and the impact of the crisis on the global supply chain from the workers on the front lines to the possibility of drug shortages.
đź’‰ DP EP 136 đź’‰ 26 March 2020
🧬
view more